Paluck Technologies IPO Day 3: GMP ₹25

Welcome back, investors! We’re diving into the third day of the Paluck Technologies BSE SME IPO subscription. As of the end of Day 3, the IPO remains completely unsubscribed across all categories – Retail, NII, and QIB. It’s still early days in the subscription window, which runs until September 1st, but a complete lack of movement at this stage is certainly something to observe closely.

Subscription Status

Let’s break down the numbers, or rather, the lack thereof. Currently, Paluck Technologies is showing 0x subscription in the Retail Investor category, 0x in the Non-Institutional Investor (NII) segment, and a flat 0x for Qualified Institutional Buyers (QIBs). The total subscription is also at a standstill at 0x. This is quite unusual, especially as we enter the final stretch of the IPO period. Typically, by Day 3, we start seeing some traction, at least in the Retail or NII portions for SME IPOs. The absence of any bids, even for a single lot of 3000 shares, is perplexing. It could indicate a few things: either investors are waiting for the very last day to make their decisions, perhaps to gauge the final sentiment, or there’s a lack of immediate interest. For SME IPOs, the QIB portion often remains unallocated if there isn’t sufficient demand, but seeing zero interest from them this early is notable.

GMP Update

Now, let’s talk about the Grey Market Premium (GMP). Interestingly, the GMP for Paluck Technologies has remained steady at ₹25 for the past couple of days, including today. This means that, unofficially, the market is valuing the stock at an expected listing price of ₹73 (Issue Price of ₹48 + GMP of ₹25). While the GMP hasn’t moved, its very presence at ₹25 suggests a positive sentiment from those trading in the grey market. It indicates a belief that the stock will list at a premium. However, the disconnect between a positive GMP and zero subscription numbers is a bit of a puzzle. Usually, a steady GMP would translate into some level of subscription, even if modest. The bottom line here is that the GMP is providing a potential upside, but the subscription data isn’t reflecting that enthusiasm yet.

Should You Apply?

Deciding whether to apply for the Paluck Technologies IPO at this stage requires a balanced perspective. On one hand, the GMP of ₹25, pointing towards an expected listing price of ₹73, offers an attractive potential return of over 50% on the issue price. This is certainly enticing for short-term gains. However, the complete lack of subscription across all categories on Day 3 is a significant red flag. It’s a strong indicator that market participants, both retail and institutional, are holding back. This could be due to various reasons, including concerns about the company’s fundamentals, the broader market sentiment for SME IPOs, or simply a strategy to wait and see. SEBI advisors often caution investors to look beyond GMP and consider the company’s business model, financials, and management quality. Given the current subscription data, it would be prudent to exercise caution. You might want to wait until the final day to see if there’s any last-minute surge in applications. If the subscription remains tepid, it might be wiser to let this one pass, despite the appealing GMP. Remember, a strong GMP without subscription isn’t a guarantee of a successful listing. It’s always best to do your own due diligence.

View Full Paluck Technologies IPO Details